This grant, offered by US Public Health Agencies, seeks to establish a national surveillance network to monitor acute gastroenteritis (AGE), acute respiratory illnesses (ARI), acute flaccid myelitis (AFM), and multisystem inflammatory syndrome in children (MIS-C). The initiative focuses on identifying these illnesses caused by various enteric and respiratory viruses in pediatric patients across inpatient, outpatient, and emergency settings. Researchers will enroll patients, confirm viral infections, and critically, calculate the effectiveness of vaccines, including those for influenza, rotavirus, and COVID-19, as well as future vaccines like RSV and norovirus. The collected data on disease burden, natural history, and vaccine effectiveness will inform best practices for diagnosis and treatment, guide vaccine recommendations, and evaluate the overall public health impact of vaccination programs in children.
Opportunity ID: 328354
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Mar 03, 2021 |
| Original Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Special district governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education County governments |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| This NOFO should be extended through Monday, March 8, 5:00pm EST. | Mar 03, 2021 | |
| Modification to update Section IV.2, pages 24-26, to clarify Content and Form of Application Submission. | Nov 17, 2020 | |
| Updated application package with the Research & Related Budget [V1.4] form. | Nov 17, 2020 | |
| Updated application package with the Research & Related Budget [V1.4] form. | Nov 17, 2020 | |
| Uploaded the revised application package. | Nov 17, 2020 | |
| na | Nov 17, 2020 | |
| Nov 17, 2020 | ||
| Jul 29, 2020 | ||
| Jul 29, 2020 |
DISPLAYING: Synopsis 7
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 7 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Mar 03, 2021 |
| Original Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Current Closing Date for Applications: | Mar 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Special district governments City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education County governments |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: |
The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 6
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 6 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Jan 12, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education: Hispanic-serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 5
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 5 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Dec 23, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 4
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 4 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Dec 23, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Dec 07, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Nov 19, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher educationThe following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education:Hispanic-serving InstitutionsHistorically Black Colleges and Universities (HBCUs)Tribally Controlled Colleges and Universities (TCCUs)Alaska Native and Native Hawaiian Serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 17, 2020 |
| Last Updated Date: | Nov 17, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Feb 08, 2021 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. |
| Archive Date: | Mar 10, 2021 |
| Estimated Total Program Funding: | $68,250,000 |
| Award Ceiling: | $1,950,000 |
| Award Floor: | $1,600,000 |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Special district governments Native American tribal governments (Federally recognized) City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Public and private non-profit institutions of higher education The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Nonprofit Institutions of Higher Education: Hispanic-serving Institutions |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this Notice of Funding Opportunity (NOFO) is to support a network of US institutions to develop and implement standard research protocols to conduct prospective active surveillance for: a) acute gastroenteritis (AGE) due to norovirus, rotavirus and other enteric viruses; b) acute respiratory illnesses (ARI) due to respiratory viruses including, but not limited to, influenza, RSV, parainfluenza viruses, human metapneumovirus, rhinoviruses, enteroviruses (including EV-D68), adenoviruses, and coronaviruses (including SARS-CoV-2); and c) acute flaccid myelitis (AFM) syndrome and multisystem inflammatory syndrome in children (MIS-C) among pediatric patients seeking healthcare at medical institutions. The network should also provide accurate estimates of the effectiveness in this population of influenza, rotavirus, COVID-19 and other vaccines against respiratory or enteric virus-associated illnesses projected to become available during the period of performance (e.g., RSV, norovirus). Participating institutions should identify AGE, ARI, AFM and MIS-C illnesses among pediatric patients seeking healthcare or diagnostic testing for acute illness in inpatient, outpatient and emergency departments. Recipients should enroll patients meeting standard symptom criteria, and confirm viral infection using approved molecular assays. Vaccine effectiveness (VE) estimates will be calculated. Estimates of VE, burden of disease, and information on the natural history of disease will be used to: a) inform best practices for diagnosis and treatment protocols; b) inform vaccine recommendations; and c) assess public health impact of vaccination and public health programs to prevent viral illness-related healthcare encounters and medical visits among pediatric populations. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Deborah Loveys
hft6@cdc.gov Email:hft6@cdc.gov |
DISPLAYING: Forecast 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 2 |
| Posted Date: | Jul 29, 2020 |
| Last Updated Date: | Nov 17, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | – |
| Estimated Total Program Funding: | $35,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $150,000 |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Special district governments City or township governments Public and State controlled institutions of higher education Small businesses |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to solicit applications for a research cooperative agreement that will fund a network of pediatric medical institutions to conduct prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, including healthy controls. The Core Component award will fund activities for a US pediatric vaccine-preventable, or possibly vaccine-preventable, disease surveillance system for a variety of AGE and ARI pathogens. The surveillance system will enable the assessment of pediatric infectious disease burden, understanding of the natural history of pediatric infectious disease, disease transmission dynamics, vaccine effectiveness evaluations and vaccine impact for vaccine-preventable pathogens or those having potential new vaccines in development. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:hft6@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-21-002 |
| Funding Opportunity Title: | Expanded Surveillance for New Vaccine Preventable Diseases |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 7 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Jul 29, 2020 |
| Last Updated Date: | Jul 29, 2020 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | – |
| Estimated Total Program Funding: | $35,000,000 |
| Award Ceiling: | $1,000,000 |
| Award Floor: | $150,000 |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education State governments County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Special district governments City or township governments Public and State controlled institutions of higher education Small businesses |
| Additional Information on Eligibility: |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The purpose of this notice of funding opportunity is to solicit applications for a research cooperative agreement that will fund a network of pediatric medical institutions to conduct prospective, active surveillance for acute gastroenteritis (AGE) and acute respiratory illnesses (ARI) in inpatient and emergency department clinical settings, including healthy controls. The Core Component award will fund activities for a US pediatric vaccine-preventable, or possibly vaccine-preventable, disease surveillance system for a variety of AGE and ARI pathogens. The surveillance system will enable the assessment of pediatric infectious disease burden, understanding of the natural history of pediatric infectious disease, disease transmission dynamics, vaccine effectiveness evaluations and vaccine impact for vaccine-preventable pathogens or those having potential new vaccines in development. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:hft6@cdc.gov |
Related Documents
Folder 328354 Full Announcement-FULL_ANNOUNCEMENT -> RFA-IP-21-002 Amend 1 03 03 21 .pdf
Folder 328354 Full Announcement-FULL_ANNOUNCEMENT -> RFA-IP-21-002.pdf
Packages
| Agency Contact Information: | Deborah Loveys hft6@cdc.gov Email: hft6@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.185 | RFA-IP-21-002 | US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children | PKG00264149 | Nov 17, 2020 | Mar 08, 2021 | View |
Package 1
Mandatory forms
328354 RR_SF424_2_0-2.0.pdf
328354 PHS398_CoverPageSupplement_5_0-5.0.pdf
328354 RR_OtherProjectInfo_1_4-1.4.pdf
328354 PHS398_ResearchPlan_4_0-4.0.pdf
328354 PerformanceSite_2_0-2.0.pdf
328354 RR_KeyPersonExpanded_2_0-2.0.pdf
328354 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
328354 RR_Budget_1_4-1.4.pdf
Optional forms
328354 RR_SubawardBudget30_1_4-1.4.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
